| |
| |
|
| Insider
Information: |
Davis Todd C |
| Relationship: |
Director |
| City: |
San Diego |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
246,065 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$10,322,221 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
246,065 |
|
|
| Total
Value |
$10,322,221 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
1
|
3
|
|
Stock
price went up :
|
1
|
1
|
| Stock
price went down : |
0
|
2
|
| |
|
|
|
Gain/Loss Ratio : |
1.0
|
1.0
|
| Percentage
Gain/Loss : |
 42.1%
|
24.6%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Ligand Pharmaceuticals Inc |
LGND |
Chief Executive Office... |
2024-03-25 |
120,160 |
2007-05-31 |
0 |
Premium* |
|
|
Biodelivery Sciences Internation... |
BDSI |
Director |
2022-03-22 |
0 |
2018-08-14 |
0 |
Premium* |
|
|
Vaxart Inc |
VXRT |
Director |
2022-08-04 |
125,905 |
2020-04-28 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| LGND |
Ligand Pharmaceuticals In... |
Director |
– • – |
2018-02-27 |
4 |
S |
$151.90 |
$1,873,709 |
D/D |
(12,335) |
53,563 |
0 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
Director |
– • – |
2018-08-16 |
4 |
S |
$239.93 |
$1,399,505 |
D/D |
(5,833) |
48,223 |
0 |
- |
|
| BDSI |
Biodelivery Sciences Inte... |
Director |
– • – |
2019-11-15 |
4 |
S |
$6.11 |
$1,222,000 |
D/D |
(200,000) |
237,914 |
0 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
Director |
– • – |
2021-02-10 |
4 |
S |
$213.14 |
$1,083,410 |
D/D |
(5,083) |
47,678 |
0 |
% |
|
| LGND |
Ligand Pharmaceuticals In... |
Chief Executive Officer |
• • – |
2024-03-25 |
4 |
OE |
$46.20 |
$919,147 |
D/D |
16,015 |
120,160 |
0 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
Director |
– • – |
2018-08-17 |
4 |
S |
$239.50 |
$758,497 |
D/D |
(3,167) |
45,056 |
0 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
Director |
– • – |
2018-02-26 |
4 |
S |
$153.58 |
$742,536 |
D/D |
(4,835) |
65,898 |
0 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
Director |
– • – |
2016-10-31 |
4 |
OE |
$32.30 |
$638,362 |
D/D |
13,980 |
70,189 |
0 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
Director |
– • – |
2018-10-08 |
4 |
AS |
$253.99 |
$634,978 |
D/D |
(2,500) |
42,556 |
0 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
Director |
– • – |
2018-10-12 |
4 |
OE |
$89.75 |
$525,021 |
D/D |
5,083 |
47,639 |
0 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
Director |
– • – |
2021-02-11 |
4 |
OE |
$195.91 |
$484,681 |
D/D |
2,474 |
50,152 |
0 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
Director |
– • – |
2014-03-19 |
4 |
S |
$79.63 |
$398,147 |
D/D |
(5,000) |
32,536 |
0 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
Director |
– • – |
2021-01-27 |
4 |
OE |
$113.50 |
$278,756 |
D/D |
2,456 |
52,761 |
0 |
- |
|
| BDSI |
Biodelivery Sciences Inte... |
Director |
– • – |
2020-08-18 |
4 |
S |
$4.99 |
$249,500 |
D/D |
(50,000) |
217,914 |
0 |
% |
|
| LGND |
Ligand Pharmaceuticals In... |
CHIEF EXECUTIVE OFFICER |
• • – |
2023-09-22 |
4 |
B |
$59.38 |
$237,529 |
D/D |
4,000 |
73,090 |
2.81 |
% |
|
| LGND |
Ligand Pharmaceuticals In... |
Director |
– • – |
2015-08-06 |
4 |
OE |
$8.58 |
$232,288 |
D/D |
19,670 |
55,449 |
0 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
Director |
– • – |
2014-03-18 |
4 |
S |
$79.45 |
$198,637 |
D/D |
(2,500) |
37,536 |
0 |
- |
|
| VXRT |
Vaxart Inc |
Director |
• • – |
2020-04-28 |
4 |
S |
$3.28 |
$196,500 |
D/D |
(60,000) |
120,000 |
0 |
% |
|
| LGND |
Ligand Pharmaceuticals In... |
Director |
– • – |
2011-08-10 |
4 |
B |
$10.90 |
$163,500 |
D/D |
15,000 |
29,201 |
2.39 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
CHIEF EXECUTIVE OFFICER |
• • – |
2024-02-15 |
4 |
D |
$74.65 |
$103,092 |
D/D |
(1,381) |
71,709 |
0 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
Director |
– • – |
2019-08-02 |
4 |
B |
$93.59 |
$93,594 |
D/D |
1,000 |
49,474 |
2.39 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
CHIEF EXECUTIVE OFFICER |
• • – |
2023-06-09 |
4 |
D |
$73.76 |
$30,979 |
D/D |
(420) |
69,090 |
0 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
Director |
– • – |
2007-05-31 |
4/A |
A |
$0.00 |
$0 |
D/D |
5,000 |
5,000 |
0 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
Director |
– • – |
2008-05-29 |
4 |
A |
$0.00 |
$0 |
D/D |
5,000 |
10,000 |
0 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
Director |
– • – |
2009-05-29 |
4 |
A |
$0.00 |
$0 |
D/D |
5,000 |
15,000 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
